Integrative machine learning models predict prostate cancer diagnosis and biochemical recurrence risk: Advancing precision oncology
Prostate cancer (PCa) ranks among the most prevalent cancers in men worldwide. Biochemical recurrence (BCR) presents a major clinical challenge in PCa management, with significant prognostic heterogeneity observed among patients post-recurrence. This study aimed…
Continue Reading